| Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids A Alpert, D Powell, RL Pacula American Economic Journal: Economic Policy 10 (4), 1-35, 2018 | 427 | 2018 |
| Origins of the opioid crisis and its enduring impacts A Alpert, WN Evans, EMJ Lieber, D Powell The Quarterly Journal of Economics 137 (2), 1139-1179, 2022 | 215 | 2022 |
| The anticipatory effects of Medicare Part D on drug utilization A Alpert Journal of health economics 49, 28-45, 2016 | 95 | 2016 |
| A transitioning epidemic: how the opioid crisis is driving the rise in hepatitis C D Powell, A Alpert, RL Pacula Health Affairs 38 (2), 287-294, 2019 | 94 | 2019 |
| Giving EMS flexibility in transporting low-acuity patients could generate substantial Medicare savings A Alpert, KG Morganti, GS Margolis, J Wasserman, AL Kellermann Health Affairs 32 (12), 2142-2148, 2013 | 87 | 2013 |
| Evaluating the role of payment policy in driving vertical integration in the oncology market A Alpert, H Hsi, M Jacobson Health Affairs 36 (4), 680-688, 2017 | 58 | 2017 |
| Prescription drug advertising and drug utilization: The role of Medicare Part D A Alpert, D Lakdawalla, N Sood Journal of public economics 221, 104860, 2023 | 52 | 2023 |
| Estimating intensive and extensive tax responsiveness A Alpert, D Powell Economic Inquiry 58 (4), 1855-1873, 2020 | 43* | 2020 |
| How do prescription drug monitoring programs reduce opioid prescribing? the role of hassle costs versus information AE Alpert, SE Dykstra, M Jacobson National Bureau of Economic Research, 2020 | 35 | 2020 |
| Perverse reverse price competition: Average wholesale prices and Medicaid pharmaceutical spending A Alpert, M Duggan, JK Hellerstein Journal of Public Economics 108, 44-62, 2013 | 35 | 2013 |
| A socioeconomic profile of older adults with HIV G Joyce, DP Goldman, AA Leibowitz, A Alpert, Y Bao Journal of Health Care for the Poor and Underserved 16 (1), 19-28, 2005 | 33 | 2005 |
| Impact of oncology drug shortages on chemotherapy treatment A Alpert, M Jacobson Clinical Pharmacology & Therapeutics 106 (2), 415-421, 2019 | 30 | 2019 |
| Should payment policy be changed to allow a wider range of EMS transport options? KG Morganti, A Alpert, G Margolis, J Wasserman, AL Kellermann Annals of Emergency Medicine 63 (5), 615-626. e5, 2014 | 27 | 2014 |
| Post-acute referral patterns for hospitals and implications for bundled payment initiatives C Lau, A Alpert, P Huckfeldt, P Hussey, D Auerbach, H Liu, N Sood, ... Healthcare 2 (3), 190-195, 2014 | 22 | 2014 |
| The state of innovative emergency medical service programs in the United States KG Morganti, A Alpert, G Margolis, J Wasserman, AL Kellermann Prehospital Emergency Care 18 (1), 76-85, 2014 | 13 | 2014 |
| Effects of payment reform in more versus less competitive markets N Sood, A Alpert, K Barnes, P Huckfeldt, JJ Escarce Journal of health economics 51, 66-83, 2017 | 12 | 2017 |
| Prescription drug shortages: Reconsidering the role of Medicare payment policies M Jacobson, A Alpert, F Duarte Health Affairs Forefront, 2012 | 7 | 2012 |
| Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market C Gray, AE Alpert, N Sood National Bureau of Economic Research, 2023 | 5 | 2023 |
| Opioid use and employment outcomes: evidence from the US military AE Alpert, S Schwab, BD Ukert National Bureau of Economic Research, 2022 | 5 | 2022 |
| Biosimilar Competition and Payments in Medicare: The Case of Trastuzumab DM Horn, AE Alpert, MG Duggan, NA Garcia, M Jacobson JCO Oncology Practice 19 (4), e476-e483, 2023 | 4 | 2023 |
